BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2019
View Archived Issues
Gene editing extends life span of progeria mice
Read More
Salt plays role in dermatitis risk
Read More
The ties that bind synapses
Read More
TBL1Y gene mutation tied to hereditary hearing loss
Read More
TC BioPharm collaborates with Trinity College Dublin on V delta 1 products for cancer
Read More
Grant to support IND submission and phase I trials of Hummingbird's HMBD-002
Read More
Imuran and Azanin approved in Japan to treat autoimmune hepatitis
Read More
Listeria shown to evade killing by hijacking host mitophagy
Read More
Lentiviral gene therapy with OTL-101 shows safety and efficacy in patients with ADA-SCID
Read More
Novel dual AAV-mediated gene therapy shows efficacy in DFNB9 mouse model
Read More
NT-I7 demonstrates tumor killing in vivo and enhances survival in mice
Read More
3B Pharmaceuticals collaborates with Boehringer Ingelheim on peptide-led drug discovery
Read More
Toll-like receptor 7/8/9 antagonists discovered at Bristol-Myers Squibb
Read More
Goldfinch Biopharma discloses TrpC5 antagonists
Read More
Servicios Cientificos Neuroinnovation patents tau protein ligands
Read More
Dyax discovers plasma kallikrein inhibitors
Read More
Detailed results from phase III trials of Dupixent in chronic rhinosinusitis with nasal polyps
Read More
Phase III POLO trial of Lynparza in pancreatic cancer meets primary endpoint of PFS
Read More
Phase III study shows subcutaneous daratumumab is noninferior to intravenous daratumumab
Read More
FDA approves Lonsurf for previously treated gastric or gastroesophageal junction adenocarcinoma
Read More
New phase I trial evaluates MK-8527 in ART-naive patients with HIV-1
Read More
Lilly synthesizes new phosphodiesterase PDE1 inhibitors
Read More
Modified mRNA encoding VEGF-A evaluated in patients with type 2 diabetes
Read More
Favorable interim phase I results for SRK-015 support progression to phase II for SMA
Read More
Debiopharm begins phase II study of afabicin for staphylococcal bone and joint infections
Read More
